As Guangdong Ganhua Science & Industry (SZSE:000576) Jumps 15% This Past Week, Investors May Now Be Noticing the Company's One-year Earnings Growth
As Guangdong Ganhua Science & Industry (SZSE:000576) Jumps 15% This Past Week, Investors May Now Be Noticing the Company's One-year Earnings Growth
Guangdong Ganhua Science & Industry Co., Ltd. (SZSE:000576) shareholders should be happy to see the share price up 15% in the last week. But that doesn't change the reality of under-performance over the last twelve months. After all, the share price is down 41% in the last year, significantly under-performing the market.
廣東贛華科工股份有限公司(SZSE: 000576)股東應該很高興看到上週股價上漲15%。但這並不能改變過去十二個月中表現不佳的現實。畢竟,去年股價下跌了41%,表現大大低於市場。
The recent uptick of 15% could be a positive sign of things to come, so let's take a look at historical fundamentals.
最近15%的上漲可能是即將發生的事情的積極信號,因此讓我們來看看歷史基本面。
While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
雖然市場是一種強大的定價機制,但股價反映了投資者的情緒,而不僅僅是潛在的業務表現。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。
The last year saw Guangdong Ganhua Science & Industry's EPS really take off. While the business is unlikely to sustain such a high growth rate for long, it's great to see. As a result, we're surprised to see the weak share price. Some different data might shed some more light on the situation.
去年,廣東甘化科工的每股收益真正騰飛。儘管該業務不太可能長期維持如此高的增長率,但很高興看到。因此,我們驚訝地看到股價疲軟。一些不同的數據可能會爲情況提供更多啓示。
Guangdong Ganhua Science & Industry's revenue is actually up 16% over the last year. Since we can't easily explain the share price movement based on these metrics, it might be worth considering how market sentiment has changed towards the stock.
廣東贛化科工的收入實際上比去年增長了16%。由於我們無法根據這些指標輕鬆解釋股價走勢,因此可能值得考慮市場對該股的情緒發生了怎樣的變化。
The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).
下圖顯示了收入和收入隨時間推移的跟蹤情況(如果您點擊圖片,可以看到更多細節)。

This free interactive report on Guangdong Ganhua Science & Industry's balance sheet strength is a great place to start, if you want to investigate the stock further.
如果你想進一步調查該股,這份關於廣東甘化科工資產負債表實力的免費互動報告是一個很好的起點。
A Different Perspective
不同的視角
While the broader market lost about 17% in the twelve months, Guangdong Ganhua Science & Industry shareholders did even worse, losing 41%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 5% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Is Guangdong Ganhua Science & Industry cheap compared to other companies? These 3 valuation measures might help you decide.
儘管整個市場在十二個月中下跌了約17%,但廣東甘化科工股東的表現甚至更糟,跌幅爲41%。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨5%的總虧損。我們意識到羅斯柴爾德男爵曾說過,投資者應該 “在街頭流血時買入”,但我們警告說,投資者應首先確保他們購買的是高質量的企業。與其他公司相比,廣東甘化科工便宜嗎?這3種估值指標可能會幫助您做出決定。
We will like Guangdong Ganhua Science & Industry better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
如果我們看到一些重大的內幕收購,我們會更喜歡廣東甘化科工。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。